Fu Jin-rong, Liu Wen-li, Zhou Yu-feng, Zhou Jian-feng, Sun Han-ying, Luo Li, Zhang Heng, Xu Hui-zhen
Department of Hematology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan 430030, China.
Chin Med J (Engl). 2005 Dec 5;118(23):1979-86.
Hematopoietic stem cells (HSCs) give rise to all blood and immune cells and are used in clinical transplantation protocols to treat a wide variety of refractory diseases, but the amplification of HSCs has been difficult to achieve in vitro. In the present study, the expansive effects of aorta-gonad-mesonephros (AGM) region derived stromal cells on HSCs were explored, attempting to improve the efficiency of HSC transplantation in clinical practice.
The murine stromal cells were isolated from the AGM region of 12 days postcoitum (dpc) murine embryos and bone marrow (BM) of 6 weeks old mice, respectively. After identification with flow cytometry and immunocytochemistry, the stromal cells were co-cultured with ESCs-derived, cytokines-induced HSCs. The maintenance and expansion of ESCs-derived HSCs were evaluated by detecting the population of CD34+ and CD34+Sca-1+ cells with flow cytometry and the blast colony-forming cells (BL-CFCs), high proliferative potential colony-forming cells (HPP-CFCs) by using semi-solid medium colonial culture. Finally, the homing and hematopoietic reconstruction abilities of HSCs were evaluated using a murine model of HSC transplantation in vivo.
AGM and BM-derived stromal cells were morphologically and phenotypically similar, and had the features of stromal cells. When co-cultured with AGM or BM stromal cells, more primitive progenitor cells (HPP-CFCs) could be detected in ESCs derived hematopoietic precursor cells, but BL-CFC's expansion could be detected only when co-cultured with AGM-derived stromal cells. The population of CD34+ hematopoietic stem/progenitor cells were expanded 3 times, but no significant expansion in the population of CD34+Sca-1+ cells was noted when co-cultured with BM stromal cells. While both CD34+ hematopoietic stem/progenitor cells and CD34+Sca-1+ cells were expanded 4 to 5 times respectively when co-cultured with AGM stromal cells. AGM region-derived stromal cells, like BM-derived stromal cells, could promote hematopoietic reconstruction and HSCs' homing to BM in vivo.
AGM-derived stromal cells in comparison with the BM-derived stromal cells could not only support the expansion of HSCs but also maintain the self-renewal and multi-lineage differentiation more effectively. They are promising in HSC transplantation.
造血干细胞(HSCs)可分化产生所有血液和免疫细胞,并用于临床移植方案以治疗多种难治性疾病,但造血干细胞的体外扩增一直难以实现。在本研究中,探索了主动脉 - 性腺 - 中肾(AGM)区来源的基质细胞对造血干细胞的扩增作用,试图提高临床实践中造血干细胞移植的效率。
分别从小鼠胚胎12天龄(dpc)的AGM区和6周龄小鼠的骨髓(BM)中分离小鼠基质细胞。经流式细胞术和免疫细胞化学鉴定后,将基质细胞与胚胎干细胞来源的、细胞因子诱导的造血干细胞共培养。通过流式细胞术检测CD34 +和CD34 + Sca-1 +细胞群体,并使用半固体培养基集落培养检测爆式集落形成细胞(BL-CFCs)、高增殖潜能集落形成细胞(HPP-CFCs),以评估胚胎干细胞来源的造血干细胞的维持和扩增情况。最后,使用体内造血干细胞移植的小鼠模型评估造血干细胞的归巢和造血重建能力。
AGM和BM来源的基质细胞在形态和表型上相似,具有基质细胞的特征。当与AGM或BM基质细胞共培养时,在胚胎干细胞来源的造血前体细胞中可检测到更多原始祖细胞(HPP-CFCs),但仅在与AGM来源的基质细胞共培养时才能检测到BL-CFCs的扩增。与BM基质细胞共培养时,CD34 +造血干/祖细胞群体扩增了3倍,但CD34 + Sca-1 +细胞群体无明显扩增。而与AGM基质细胞共培养时,CD34 +造血干/祖细胞和CD34 + Sca-1 +细胞群体分别扩增了4至5倍。AGM区来源的基质细胞与BM来源的基质细胞一样,可促进体内造血重建和造血干细胞归巢至骨髓。
与BM来源的基质细胞相比,AGM来源的基质细胞不仅能支持造血干细胞的扩增,还能更有效地维持其自我更新和多系分化。它们在造血干细胞移植方面具有广阔前景。